EXPRESSION LEVELS OF BCL-xL, BCL2, BCL-w, AND BAD AND CANCER THERAPIES von SIMS, Robert, Joseph, III, CENTORE, Richard, C, MERTZ, Jennifer, Andrea, CONERY, Andrew, Ryan

Volltext bestellen

EXPRESSION LEVELS OF BCL-XL, BCL2, BCL-W, AND BAD AND CANCER THERAPIES von Sims, III Robert Joseph, Mertz Jennifer Andrea, Conery Andrew Ryan, Centore Richard C

Volltext bestellen

EXPRESSION LEVELS OF BCL-xL, BCL2, BCL-w, AND BAD AND CANCER THERAPIES von MERTZ, JENNIFER, ANDREA, SIMS, ROBERT, JOSEPH, III, CONERY, ANDREW, RYAN, CENTORE, RICHARD, C

Volltext bestellen

EXPRESSION LEVELS OF BCL-xL, BCL2, BCL-w, AND BAD AND CANCER THERAPIES von MERTZ, JENNIFER, ANDREA, SIMS, ROBERT, JOSEPH, III, CONERY, ANDREW, RYAN, CENTORE, RICHARD, C

Volltext bestellen

Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition von Ghosh, Srimoyee, Taylor, Alexander, Chin, Melissa, Huang, Hon-Ren, Conery, Andrew R., Mertz, Jennifer A., Salmeron, Andres, Dakle, Pranal J., Mele, Deanna, Cote, Alexandre, Jayaram, Hari, Setser, Jeremy W., Poy, Florence, Hatzivassiliou, Georgia, DeAlmeida-Nagata, Denise, Sandy, Peter, Hatton, Charlie, Romero, F. Anthony, Chiang, Eugene, Reimer, Thornik, Crawford, Terry, Pardo, Eneida, Watson, Venita G., Tsui, Vickie, Cochran, Andrea G., Zawadzke, Laura, Harmange, Jean-Christophe, Audia, James E., Bryant, Barbara M., Cummings, Richard T., Magnuson, Steven R., Grogan, Jane L., Bellon, Steve F., Albrecht, Brian K., Sims, Robert J., Lora, Jose M.

Volltext

Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study von Dewidar, Omar, Bondok, Mostafa, Abdelrazeq, Leenah, Aliyeva, Khadija, Solo, Karla, Welch, Vivian, Brignardello-Petersen, Romina, Mathew, Joseph L, Hazlewood, Glen, Pottie, Kevin, Hartling, Lisa, Khalifa, Dina Sami, Duda, Stephanie, Falavigna, Maicon, Khabsa, Joanne, Lotfi, Tamara, Petkovic, Jennifer, Elliot, Sarah, Chi, Yuan, Parker, Roses, Kristjansson, Elizabeth, Riddle, Alison, Darzi, Andrea J, Magwood, Olivia, Saad, Ammar, Rada, Gabriel, Neumann, Ignacio, Loeb, Mark, Reveiz, Ludovic, Mertz, Dominik, Piggott, Thomas, Turgeon, Alexis F, Schünemann, Holger, Tugwell, Peter

Volltext

Preliminary Report of MANIFEST, a Phase 2 Study of CPI-0610, a Bromodomain and Extraterminal Domain Inhibitor (BETi), in Combination with Ruxolitinib, in JAK Inhibitor (JAKi) Treat... von Harrison, Claire N, Patriarca, Andrea, Mascarenhas, John, Kremyanskaya, Marina, Hoffman, Ronald, Schiller, Gary J., Leber, Brian, Devos, Timothy, Kabir, Sujan, Senderowicz, Adrian, Mertz, Jennifer, Trojer, Patrick, Shao, James, Gupta, Vikas

Volltext